Friday, 4 June 2021

Lupin Launches Authorized Generic Version of Brovana in the United States

Lupin Launches Authorized Generic Version of Brovana in the United States
Lupin Launches Authorized Generic Version of Brovana in the United States

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

Global pharma major, Lupin Limited (Lupin), announced the launch of the authorized generic version of Brovana® (arformoterol tartrate) Inhalation Solution 15 mcg/2 mL, unit-dose vials, of Sunovion Pharmaceuticals Inc.

admin Fri, 06/04/2021 - 15:31

source https://www.pharmatutor.org/pharma-news/2021/lupin-launches-authorized-generic-version-of-brovana-in-the-united-states

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...